Skip to main content

Advertisement

SpringerLink
Log in

Arterial therapies of non-colorectal cancer metastases to the liver (from chemoembolization to radioembolization)

  • Published:
Abdominal Imaging Aims and scope Submit manuscript

Abstract

Treatment of primary and secondary hepatic malignancies with transarterial chemoembolization (TACE) represents an essential component of interventional oncology known for many years and performed by many interventional radiologists first in primary liver tumors and nowadays even in metastases of different origins. Radioembolization (RE) has been introduced to the clinical arsenal of cytoreductive modalities in recent years. There is growing evidence for efficiency in liver tumors of various entities, with the most prominent ones being hepatocellular carcinoma, colorectal cancer, and neuroendocrine tumors. Hepatic metastases of other tumor entities (breast cancer, malignant melanoma, and pancreatic cancer) are treatment-sensitive. This article focuses on procedural and technical aspects for selection, preparation, and performance of treatment as well as the results in metastatic breast cancer, neuroendocrine tumors, melanoma, and pancreatic cancer giving an overview of the results after RE, transarterial embolization, or TACE.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Salem R, Thurston KG (2006) Radioembolization with 90Yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 1: technical and methodologic considerations. J Vasc Interv Radiol 17(8):1251–1278

    Article  PubMed  Google Scholar 

  2. Abdalla EK, et al. (2004) Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 239(6):818–825 (discussion 825–827)

    Article  PubMed  Google Scholar 

  3. Mulcahy MF, et al. (2009) Radioembolization of colorectal hepatic metastases using yttrium-90 microspheres. Cancer 115(9):1849–1858

    Article  PubMed  Google Scholar 

  4. Breedis C, Young G (1954) The blood supply of neoplasms in the liver. Am J Pathol 30(5):969–977

    PubMed  CAS  Google Scholar 

  5. Lammer J, et al. (2010) Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study. Cardiovasc Intervent Radiol 33(1):41–52

    Article  PubMed  Google Scholar 

  6. Raoul JL, et al. (1992) Chemoembolization of hepatocellular carcinomas. A study of the biodistribution and pharmacokinetics of doxorubicin. Cancer 70(3):585–590

    Article  PubMed  CAS  Google Scholar 

  7. Gonsalves CF, Brown DB (2009) Chemoembolization of hepatic malignancy. Abdom Imaging 34:557–565

    Article  PubMed  Google Scholar 

  8. Chen MS, et al. (2002) High-dose iodized oil transcatheter arterial chemoembolization for patients with large hepatocellular carcinoma. World J Gastroenterol 8(1):74–78

    PubMed  Google Scholar 

  9. Higashi S, et al. (1999) Size of lipid microdroplets effects results of hepatic arterial chemotherapy with an anticancer agent in water-in-oil-in-water emulsion to hepatocellular carcinoma. J Pharmacol Exp Ther 289(2):816–819

    PubMed  CAS  Google Scholar 

  10. Touzios JG, et al. (2005) Neuroendocrine hepatic metastases: does aggressive management improve survival? Ann Surg 241(5):776–783 (discussion 783–785)

    Article  PubMed  Google Scholar 

  11. Yip D, et al. (2004) Radiation-induced ulceration of the stomach secondary to hepatic embolization with radioactive yttrium microspheres in the treatment of metastatic colon cancer. J Gastroenterol Hepatol 19(3):347–349

    Article  PubMed  Google Scholar 

  12. Lau WY, et al. (1998) Selective internal radiation therapy for nonresectable hepatocellular carcinoma with intraarterial infusion of 90yttrium microspheres. Int J Radiat Oncol Biol Phys 40(3):583–592

    Article  PubMed  CAS  Google Scholar 

  13. Ibrahim SM, Nikolaidis P, Miller FG, et al. (2009) Radiologic findings following Y90 radioembolization for primary liver malignancies. Abdom Imaging 34:566–581

    Article  PubMed  Google Scholar 

  14. Riaz A, et al. (2009) Complications following radioembolization with yttrium-90 microspheres: a comprehensive literature review. J Vasc Interv Radiol 20(9):1121–1130 (quiz 1131)

    Article  PubMed  Google Scholar 

  15. Viadana E, Bross ID, Pickren JW (1973) An autopsy study of some routes of dissemination of cancer of the breast. Br J Cancer 27(4):336–340

    Article  PubMed  CAS  Google Scholar 

  16. Giroux MF, Baum RA, Soulen MC (2004) Chemoembolization of liver metastasis from breast carcinoma. J Vasc Interv Radiol 15(3):289–291

    PubMed  Google Scholar 

  17. Jakobs TF, et al. (2008) Radioembolization in patients with hepatic metastases from breast cancer. J Vasc Interv Radiol 19(5):683–690

    Article  PubMed  Google Scholar 

  18. Bangash AK, et al. (2007) 90Y radioembolization of metastatic breast cancer to the liver: toxicity, imaging response, survival. J Vasc Interv Radiol 18(5):621–628

    Article  PubMed  Google Scholar 

  19. Coldwell DM, Kennedy AS, Nutting CW (2007) Use of yttrium-90 microspheres in the treatment of unresectable hepatic metastases from breast cancer. Int J Radiat Oncol Biol Phys 69(3):800–804

    Article  PubMed  CAS  Google Scholar 

  20. Murthy R, et al. (2008) Yttrium-90 microsphere radioembolotherapy of hepatic metastatic neuroendocrine carcinomas after hepatic arterial embolization. J Vasc Interv Radiol 19(1):145–151

    Article  PubMed  Google Scholar 

  21. Madoff DC, et al. (2006) Update on the management of neuroendocrine hepatic metastases. J Vasc Interv Radiol 17(8):1235–1249 (quiz 1250)

    Article  PubMed  Google Scholar 

  22. Gonsalves CF, Brown DB (2009) Chemoembolization of hepatic malignancy. Abdom Imaging 34(5):557–565

    Article  PubMed  Google Scholar 

  23. Gupta S, et al. (2005) Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: variables affecting response rates and survival. Cancer 104(8):1590–1602

    Article  PubMed  Google Scholar 

  24. Rhee TK, et al. (2008) 90Y Radioembolization for metastatic neuroendocrine liver tumors: preliminary results from a multi-institutional experience. Ann Surg 247(6):1029–1035

    Article  PubMed  Google Scholar 

  25. Kennedy AS, et al. (2008) Radioembolization for unresectable neuroendocrine hepatic metastases using resin 90Y-microspheres: early results in 148 patients. Am J Clin Oncol 31(3):271–279

    Article  PubMed  Google Scholar 

  26. Ahmadzadehfar H, Biersack HJ, Ezziddin S (2010) Radioembolization of liver tumors with yttrium-90 microspheres. Semin Nucl Med 40(2):105–121

    Article  PubMed  Google Scholar 

  27. Kalinowski M, et al. (2009) Selective internal radiotherapy with Yttrium-90 microspheres for hepatic metastatic neuroendocrine tumors: a prospective single center study. Digestion 79(3):137–142

    Article  PubMed  Google Scholar 

  28. Mavligit GM, et al. (1988) Regression of ocular melanoma metastatic to the liver after hepatic arterial chemoembolization with cisplatin and polyvinyl sponge. JAMA 260(7):974–976

    Article  PubMed  CAS  Google Scholar 

  29. Bedikian AY, et al. (1995) Treatment of uveal melanoma metastatic to the liver: a review of the M. D. Anderson Cancer Center experience and prognostic factors. Cancer 76(9):1665–1670

    Article  PubMed  CAS  Google Scholar 

  30. Sharma KV, et al. (2008) Hepatic arterial chemoembolization for management of metastatic melanoma. AJR Am J Roentgenol 190(1):99–104

    Article  PubMed  Google Scholar 

  31. Schuster R, et al. (2010) Transarterial chemoembolization of liver metastases from uveal melanoma after failure of systemic therapy: toxicity and outcome. Melanoma Res 20(3):191–196

    PubMed  CAS  Google Scholar 

  32. Kennedy AS, et al. (2009) A first report of radioembolization for hepatic metastases from ocular melanoma. Cancer Invest 27(6):682–690

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute and Clinic for Radiology, University Hospital of Dresden, Fetscherstr. 74, 01307, Dresden, Germany

    Ralf Thorsten Hoffmann

  2. Institute of Clinical Radiology, University of Munich, Campus Grosshadern, Marchioninistrasse 15, Munich, Germany

    P. Paprottka, T. F. Jakobs, C. G. Trumm & M. F. Reiser

Authors
  1. Ralf Thorsten Hoffmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. Paprottka
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. T. F. Jakobs
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. C. G. Trumm
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. M. F. Reiser
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ralf Thorsten Hoffmann.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hoffmann, R.T., Paprottka, P., Jakobs, T.F. et al. Arterial therapies of non-colorectal cancer metastases to the liver (from chemoembolization to radioembolization). Abdom Imaging 36, 671–676 (2011). https://doi.org/10.1007/s00261-011-9753-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00261-011-9753-6

Keywords

Search

Navigation